Barclays Cuts Omada Health (NASDAQ:OMDA) Price Target to $17.00

Omada Health (NASDAQ:OMDA) had its price target cut by Barclays from $22.00 to $17.00 in a research report released on Tuesday,Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also recently issued reports about the stock. Needham & Company LLC reissued a “buy” rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. Morgan Stanley set a $32.00 target price on shares of Omada Health in a research report on Thursday, December 18th. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $26.00 price objective on shares of Omada Health in a report on Friday, January 16th. Finally, Wells Fargo & Company began coverage on Omada Health in a research report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $24.60.

Omada Health Trading Up 0.6%

Shares of OMDA opened at $13.60 on Tuesday. Omada Health has a 12 month low of $10.28 and a 12 month high of $28.40. The business’s fifty day simple moving average is $14.07 and its two-hundred day simple moving average is $18.73. The company has a market cap of $787.58 million and a price-to-earnings ratio of -54.40.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, March 5th. The company reported $0.08 EPS for the quarter. The business had revenue of $75.85 million for the quarter.

Insiders Place Their Bets

In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the business’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the completion of the sale, the president owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Sean P. Duffy sold 40,796 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $15.95, for a total value of $650,696.20. Following the completion of the transaction, the chief executive officer directly owned 126,644 shares in the company, valued at $2,019,971.80. This trade represents a 24.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 276,893 shares of company stock valued at $4,336,787.

Institutional Investors Weigh In On Omada Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OMDA. Teacher Retirement System of Texas bought a new stake in Omada Health during the 2nd quarter worth approximately $640,000. Geode Capital Management LLC purchased a new stake in shares of Omada Health in the second quarter worth $637,000. Franklin Resources Inc. bought a new stake in shares of Omada Health during the 2nd quarter valued at $2,695,000. Eisler Capital Management Ltd. purchased a new position in shares of Omada Health during the 2nd quarter valued at $545,000. Finally, XTX Topco Ltd bought a new position in Omada Health in the 2nd quarter worth $414,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.